Stocks / ABSI vs AKTS

Absci Corporation (ABSI) vs Aktis Oncology, Inc. (AKTS)

Absci Corporation and Aktis Oncology, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

AKTS is the larger company ($1.0B vs $1.0B). On the fundamentals, AKTS earns a higher net margin (-980.9% vs -4113.7%); AKTS has the stronger return on equity (43.6% vs -60.8%). On the filings, AKTS carries fewer potential red flags (1 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — ABSI vs AKTS, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 Absci Corporation (ABSI)Aktis Oncology, Inc. (AKTS)
Market cap$1.0B$1.0B
Revenue (latest FY)$2.80M$6.50M
Net income (latest FY)$-115.18M$-63.73M
Revenue growth (5y CAGR)-10.1%
Net margin-4113.7%-980.9%
Return on equity-60.8%43.6%
P/E ratio
Dividend yield
Profitable years (of last 10)00
Positive free cash flowNoNo

Performance — ABSI vs AKTS

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 Absci Corporation (ABSI)Aktis Oncology, Inc. (AKTS)
1-year return146.3%
3-year return316.4%
5-year return
10-year return
52-week range$2.24–$7.39$14.72–$29.16

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full ABSI vs AKTS breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open ABSI's full financials →   Open AKTS's full financials →

More comparisons

Frequently asked questions

Which is bigger, ABSI or AKTS?

Aktis Oncology, Inc. is larger by market capitalization — $1.0B versus $1.0B.

Which grows faster, ABSI or AKTS?

Five-year growth data is not available for both companies.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

ABSI fundamentals → · AKTS fundamentals → · All 1,500+ companies → · Free screener →